Company intelligence / Profile preview
MAS Life Science
Daejeon, Daejeon, South Korea
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
MAS Life Science is a South Korean biotechnology company focused on developing small molecule therapeutics for metabolic and aging-related diseases. Their lead program, MAS-101, targets mitochondrial dysfunction to treat nonalcoholic steatohepatitis (NASH) and liver fibrosis. The company utilizes a proprietary platform to identify mitochondrial modulators that regulate energy metabolism and cellular health.
- Therapeutic areas
- EndocrinologyGastroenterologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Korea Research Institute of Chemical Technology (KRICT)
Beyond the preview
Go deeper on MAS Life Science.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MAS Life Science.